tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Sanofi price target lowered to EUR 101 from EUR 104 at Guggenheim

Guggenheim lowered the firm’s price target on Sanofi (SNY) to EUR 101 from EUR 104 and keeps a Buy rating on the shares after updating the firm’s model ahead of Q3 results following a check-in with IR. The firm also notes there has been increasing interest from investors on the possibility of a Dupixent settlement that could extend the product loss of exclusivity beyond the assumed current expiration in the wake of a series of recent patent settlements.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1